
|Articles|September 1, 2003
Allergy drug efficacy confirmed at molecular level
Fort Lauderdale, FL-Olopatadine hydrochlo-ride ophthalmic solution (Patanol, Alcon) reduces the release of mast-cell-derived mediators and their allergic effects in the eyes of patients with allergic conjunctivitis, according to Andrea Leonardi, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
SpyGlass Pharma releases positive data from 2 trials of Bimatoprost Drug Pad-IOL System
2
Beyond the surface: Tackling complex dry eye cases
3
Redefining glaucoma care: Where innovation meets clinical insight
4
An Extreme Case of Demodex Blepharitis: From Misdiagnosis to Remarkable Recovery
5



















































.png)


